RCI: Weight-loss drug approved to treat sleep apnea in Canada

RCI / Nicole Ireland (new window) · The Canadian Press

Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.

The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved (new window) for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked….

To read the full article on the official website, click here.